SEHK:6618Consumer Retailing
A Look At JD Health International’s Valuation As It Secures CF PharmTech Online Launch Partnership
JD Health International (SEHK:6618) is back in focus after CF PharmTech selected the company as its exclusive online launch partner for key respiratory and rhinology drugs over the next three years.
See our latest analysis for JD Health International.
The CF PharmTech agreement comes as JD Health’s share price sits at HK$48.96, with a 7 day share price return of 2.68% but a 30 day share price return decline of 5.76%. The 1 year total shareholder return of 48.36% contrasts with a 3 year total...